Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's Laboratories reports marginal fall in Q1 consolidated net profit

Date: 29-07-2024

Dr. Reddy's Laboratories has reported results for first quarter ended June 30, 2024 (Q1FY25). 

The company has reported 13.55% fall in its net profit at Rs 1417.20 crore for the quarter ended June 30, 2024 as compared to Rs 1639.40 crore for the same quarter in the previous year. However, total income of the company increased by 6.84% at Rs 6059.00 crore for Q1FY25 as compared to Rs 5670.90 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 0.90% fall in its net profit at Rs 1392.40 crore for the quarter ended June 30, 2024 as compared to Rs 1405.00 crore for the same quarter in the previous year. However, total income of the company increased by 13.72% at Rs 7883.30 crore for Q1FY25 as compared to Rs 6931.90 crore for the corresponding quarter previous year.